ZMPSTE24 and progeroid syndrome: A similar strategy was successfully tested in vivo in Zmpste24−/− and LmnaG609G/G609G progeria mice, resulting in improved body weight, extended lifespan and improvement of several HGPS phenotypes (Osorio et al. 2011).